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Increasing evidence suggests that single nucleotide polymorphisms (SNPs) associated
with complex traits are more likely to be expression quantitative trait loci (eQTLs).
Incorporating eQTL information hence has potential to increase power of genome-wide
association studies (GWAS). In this paper, we propose using eQTL weights as prior
information in SNP based association tests to improve test power while maintaining
control of the family-wise error rate (FWER) or the false discovery rate (FDR). We apply
the proposed methods to the analysis of a GWAS for childhood asthma consisting of 1296
unrelated individuals with German ancestry. The results confirm that eQTLs are enriched
for previously reported asthma SNPs. We also find that some SNPs are insignificant
using procedures without eQTL weighting, but become significant using eQTL-weighted
Bonferroni or Benjamini–Hochberg procedures, while controlling the same FWER or FDR
level. Some of these SNPs have been reported by independent studies in recent literature.
The results suggest that the eQTL-weighted procedures provide a promising approach for
improving power of GWAS. We also report the results of our methods applied to the
large-scale European GABRIEL consortium data.
Keywords: asthma, family-wise error rate, false discovery rate, eQTL, genome-wide association study, weighted
hypothesis test
INTRODUCTION
Asthma is a disorder characterized by inflamed mucosa of small
airways of lung, causing wheezing and shortness of breath
(Moffatt et al., 2010). Among the most common chronic dis-
eases of childhood, asthma has been reported to affect more
than 10% of children in many westernized societies (Cookson,
2004). It is caused by a combination of genetic and environmental
factors (Cookson, 2004; Moffatt et al., 2007), and several genome-
wide association studies (GWAS) have been conducted to study
the genetic basis underlying the complex disorder. More than
50 single nucleotide polymorphisms (SNPs) have been reported
to be associated with asthma, according to the GWAS catalog
(www.genome.gov/gwastudies, accessed on January 15, 2013).
Remarkably, the recent report (Moffatt et al., 2010) from the
GABRIEL (A Multidisciplinary Study to Identify the Genetic and
Environmental Causes of Asthma in the European Community)
consortium identified several SNPs reaching genome-wide signif-
icance through a large-scale meta-analysis.
Prior biological information, often available in practice, has
potential to increase power of GWAS. The common practice of
GWAS, “agnostic” in some sense, assumes no prior informa-
tion about any of the SNPs under investigation, meaning that all
the SNPs have an equal likelihood of being causal. Some recent
studies have taken advantage of information from linkage analysis
(Roeder et al., 2006) and gene expression (Xiong et al., 2012)
in genome-wide association scans. In genetic studies of etiol-
ogy of asthma, it is of our particular interest to employ similar
approaches and explore potentials of power gain in identifying
asthma-associated SNPs by incorporating expression quantitative
trait loci (eQTL) information.
Catalogs of eQTLs in multiple tissues have been made publicly
available, resulting from recent efforts of GWAS of gene expres-
sions (Stranger et al., 2005, 2007, 2012; Dixon et al., 2007; Dimas
et al., 2009; Yang et al., 2010). eQTLs provide insight into biol-
ogy of transcription regulation. It has been shown that eQTLs
are enriched for SNPs associated with complex diseases and traits
using GWAS (Cookson et al., 2009; Nicolae et al., 2010). eQTL
results can be used to provide functional interpretation for find-
ings from GWAS (Moffatt et al., 2007; Heid et al., 2010; Hsu
et al., 2010; Lango Allen et al., 2010; Speliotes et al., 2010; Chu
et al., 2011; Wu et al., 2012) and prioritize genes in an associa-
tion region for carrying out functional experiments using animal
models (Teslovich et al., 2010). Focusing on eQTLs may also
be useful to identify genetic pathways associated with the risk
of complex diseases and traits, such as basal cell carcinoma in
a skin cancer GWAS (Zhang et al., 2012) and type 2 diabetes
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(Zhong et al., 2010). Other results show that many cis eQTLs are
shared across tissues (Ding et al., 2010) and that a comprehensive
eQTL catalog in one tissue might be used to increase the power of
capturing relevant transcripts for other diseases (including those
that are only weakly or incidentally expressed in tissues where
eQTL information was collected).
As single-SNP analysis still remains the most popular in
GWAS, we focus on those methods designed for this type of
analysis. Single-SNP analysis tests one SNP at a time for associ-
ation by scanning across the whole genome, and hence involves a
large number of hypotheses. To correct for multiple comparisons,
statistical methods have been proposed and applied to control
for the family-wise error rate (FWER) (Bonferroni, 1936; Holm,
1979) or the false discovery rate (FDR) (Benjamini andHochberg,
1995; Storey and Tibshirani, 2003). Recent advances in statistical
methodology make it possible to incorporate prior information
through weighted hypothesis testing. In several of such methods
(Genovese et al., 2006; Roeder et al., 2006, 2007), hypotheses are
up-weighted or down-weighted based on prior likelihood of asso-
ciation with the trait of interest. While keeping the FWER or FDR
under control, the procedures can improve power with informa-
tive weights and suffer small loss in power with uninformative
weights (Genovese et al., 2006; Roeder and Wasserman, 2009).
This feature is appealing as compared to prescreening SNPs based
on prior information (e.g., to consider only eQTLs for associa-
tion testing). In this paper, we propose to use eQTLs as prior
information, and apply these weighted hypothesis testing meth-
ods to reanalyze the MAGICS (Multicentre Asthma Genetics in
Childhood Study) data of asthma GWAS (Moffatt et al., 2007) as
well as the GABRIEL meta-study of asthma (Moffatt et al., 2010).
RESULTS
PUBLISHED ASTHMA ASSOCIATIONS ARE ENRICHEDWITH eQTLs
We extracted published asthma associations from the GWAS
catalog maintained by the National Human Genome Research
Institute. As of January 15, 2013, 52 distinct reference SNPs in or
near more than 40 genes have been reported to be associated with
asthma (Table A1). According to the eQTL database (described in
Materials and Methods), 20 of these 52 SNPs (38.5%) are eQTLs.
Using the proxy SNP search tool SNAP (Johnson et al., 2008), we
then obtained an extended list of 506 SNPs that were either in the
GWAS catalog or in strong linkage disequilibrium (LD) with the
52 SNPs (r2 ≥ 0.8). We called all these 506 SNPs the extended set
of asthma-associated SNPs.
We calculated an eQTL enrichment p-value (Hosack et al.,
2003) using the MAGICS data. There are 300,821 SNPs that
passed quality control in the MAGICS data. Among these SNPs,
29 SNPs are in the GWAS catalog, and 64 SNPs are among
the 506 extended asthma-associated SNPs defined previously. To
account for the LD between SNPs in the calculation of enrich-
ment p-value, we conducted LD pruning with the r2 threshold
of 0.8 on the 300,821 SNPs. This resulted in 251,826 SNPs and
38 of them are extended asthma-associated SNPs according to
the GWAS catalog. According to the eQTL database, 22,922 SNPs
(9.1% of 251,826 SNPs) are eQTLs, and 13 asthma associated
SNPs (34.2% of 38 SNPs) are eQTLs. The corresponding enrich-
ment p-value is 6.78 × 10−5, suggesting the asthma associations
are enriched with eQTLs in the MAGICS data. Note that other
analyses considered all the SNPs rather than the pruned set of
SNPs.
These results are in line with the previous findings (Nicolae
et al., 2010), which studied the eQTLs in lymphoblastoid cell lines
(LCL) from the HapMap samples and the GWAS catalog. Their
results suggest that SNPs associated with complex traits are more
likely to be eQTLs.
WEIGHTS USING eQTL INFORMATION
We calculated two kinds of weights using eQTL information for
the MAGICS data. All the 300,821 SNPs passing quality control
were considered. First, we defined a SNP as an eQTL SNP if
it was labeled as an eQTL in the eQTL database (see details in
Materials and Methods). There are 31,781 cis eQTL SNPs (10.6%
of 300,821 SNPs) according to the definition, and for each of
them, we retrieved an eQTL p-value peQTL. Next, we considered
two choices of weights, the general weight and the binary weight.
The general weight is wg =
√
−log10p eQTL for an eQTL SNP,
and wg = 1 otherwise. The binary weight takes only two possible
values, wb = 3.70 for any eQTL SNP and wb = 0.68 otherwise.
The two values of the binary weight were chosen to maximize
the minimum power while keeping at least 10.6% (also the
percentage of eQTL SNPs) of all the hypotheses with a power
of 60%. The parameters for calculating the binary weight are
 = 0.106, α = 0.05, and β = 0.4 (see details in Materials and
Methods). Last, both weights were normalized to have the mean
equal to 1 which is necessary for the weighted hypothesis testing
methods to maintain the correct FWER or FDR (Genovese et al.,
2006). After normalization, the general weight wg has a mean of
2.44 and a median of 2.21 among eQTL SNPs, while the binary
weight wb is 3.70 for all eQTL SNPs (Figure 1).
WEIGHTED HYPOTHESIS TESTING
We applied the weighted hypothesis testing methods (Genovese
et al., 2006; Roeder and Wasserman, 2009) using the general
weight wg and the binary weight wb to the MAGICS data. For
each of the 300,821 SNPs, we calculated the trait association p-
value, p, from the single-SNP association test on the phenotypes
of asthma status, as well as the weighted p-values Qg = p/wg and
Qb = p/wb. Multiple testing adjustments were done for both the
original p-values (p) and the weighted p-values (Qg and Qb).
Bonferroni (1936) and Holm’s (1979) methods were considered
to control for FWER, and Benjamini and Hochberg’s (1995)
method was used to control for FDR.
We first ranked the SNPs using their p-values in the ascending
order, and compared the ranks based on the weighted p-values
with those based on the original p-values (Figure 2). Since only
10.6% SNPs are eQTL SNPs according to the eQTL database, and
hypotheses for eQTL SNPs are up-weighted, eQTLs generally have
higher ranks after weighting, and non-eQTLs’ ranks are lower but
themagnitude of changes is small. This is true for both the general
and binary weights. When restricting to the 29 asthma-associated
SNPs reported in the GWAS catalog, we also observed similar
behaviors, suggesting that weighting hypotheses may improve
power using informative weights, and sacrifice a little power using
uninformative weights (Roeder andWasserman, 2009).
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FIGURE 1 | Weights used in the MAGICS analysis. Each weight
corresponds to a SNP and a hypothesis. The weights have been normalized
to have mean 1 and shown in the ascending order. (A) The weights are based
on the square root of − log10 peQTL where peQTL is the eQTL p-value; (B) the
weights take only two possible values, which are decided using the method
described in Materials and Methods.
We then looked at the Q–Q plots of the original and weighted
p-values. For p-values greater than 0.0001, the Q–Q curves
(Figure 3) are similar between the original and weighted p-values,
regardless of the weights used. For those p-values less than 0.0001,
some weighted p-values are smaller than original ones, and the
difference is larger using the binary weight. We also observed that
3 asthma-associated SNPs in the GWAS catalog are among the top
SNPs with original p-values less than 10−6. The weighted p-values
for all the 3 asthma-associated SNPs are smaller than original
ones.
Next, we applied the methods to control for the FWER. An
effective ratio of 0.791 (Li et al., 2012) was used to calculate the
effective number of SNPs (300,821 × 0.791). Controlling for an
FWER level of 0.05, we obtained significant SNPs using both
the original and weighted p-values. Both Bonferroni and Holm’s
methods gave the same results, and both weights (binary and gen-
eral) also gave the same results (Tables A2, A3). The unweighted
hypothesis testing claimed 6 SNPs to be significant, all on chro-
mosome 17, including 2 asthma-associated SNPs (rs3894194
with GSDMA, and rs7216389 with ORDML3) that have been
reported previously (Moffatt et al., 2007, 2010). After applying
the weighted hypothesis testing, we obtained 9 significant SNPs
including all the 6 SNPs identified by the unweighted method,
although the ranks are not exactly the same. The 3 SNPs addi-
tionally identified by eQTL weighting were rs3902025, rs4795405,
and rs2305480. The SNP rs2305480, a missense SNP in the gene
GSDMB, was not reported in the previous GWAS study (Moffatt
et al., 2007) but has been reported as an asthma-associated SNP
in a later larger scale study by the GABRIEL consortium (includ-
ing the MAGIC data, Moffatt et al., 2010) and was found to be
strongly interacting with exposure to tobacco smoke in early life
(Bouzigon et al., 2008). We found that rs2305480 is actually in
LD (r2 = 0.702, D′ = 0.926) with rs7216389 that was identified
by the unweighted methods, suggesting that rs2305480 may not
represent a new association. Using a stringent r2 threshold of 0.4,
we found that the other two SNPs, rs3902025 and rs4795405, are
also in LD with at least one SNP identified by the unweighted
methods. So there is no new association identified by the weighted
methods in this particular analysis.
Besides controlling for FWER, we also used Benjamini and
Hochberg’s (BH) procedure (Benjamini and Hochberg, 1995) to
control for a FDR level of 0.05 (Table A4). Based on the original
p-values without weighting, the BH procedure gave 11 positive
results (SNPs). The weighted BH procedures based on the general
weight and the binary weight resulted in 7 and 8 additional posi-
tive results (SNPs), respectively. Using a stringent r2 threshold of
0.4, we found that 5 SNPs (Table 1) are not in LD with any of the
SNPs identified without weighting. Although none of the 5 SNPs
are, or in LD with, any asthma-associated SNPs according to the
GWAS catalog, there are some SNPs that seem interesting. Some
of the SNPs are in or close to the genes PGAP3 and STARD3 on
chromosome 17, and interestingly, rs2941504 has been reported
in a recent independent study (Anantharaman et al., 2011) to
be associated with asthma, although it does not meet the cri-
teria for inclusion in the GWAS catalog. This suggests that the
reanalysis using the eQTL weighting approaches is promising and
potentially useful.
REANALYSIS OF THE GABRIEL DATA
As another application, we reanalyzed the GABRIEL data using
the eQTL weighted approaches. Since only the p-values are nec-
essary for the use of eQTL weighting, we took the p-values of the
meta analysis of 37 studies that were calculated based on imputed
data. In total, there are 2,473,850 SNPs and their p-values avail-
able in the GABRIEL study, which include 267,350 out of 268,204
eQTL SNPs in the eQTL database. The weights based on eQTL
information were calculated in the similar way to the MAGICS
data analysis.
We applied Bonferroni and Holm’s methods with an FWER
level of 0.05, as well as the BH procedure with an FDR level of
0.05. An effective ratio of 0.30 (Li et al., 2012) was used to cal-
culate the effective number of SNPs (2,473,850 × 0.30). After
obtaining the lists of significant SNPs using different methods,
we report any SNPs identified by eQTL weighting that are not in
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FIGURE 2 | Rankings of the SNPs based on original p-values and
weighted p-values in the MAGICS analysis. (A) Original ranks of
eQTLs compared to their new ranks based on the general weight;
(B) original ranks of non-eQTLs compared to their new ranks based
on the general weight; (C) original ranks of eQTLs compared to their
new ranks based on the binary weight; (D) original ranks of
non-eQTLs compared to their new ranks based on the binary weight.
The black circles represent the reported asthma-associated SNPs in the
GWAS catalog, and the gray circles represent the rest of the SNPs in
the data.
LD with any SNPs identified by unweighted methods using an r2
threshold of 0.4. Such SNPs may be informative and suggest new
associations. Tables 2 and 3 show the SNPs that were identified
based on the general weight and the binary weight, respectively.
SIZE SIMULATIONS ON FWER
We conducted simulations using 5000 permutations based on the
MAGICS data, and calculated the percentage of having at least
one false positive claimed by Bonferroni and Holm’s methods
(α = 0.05, with an effective ratio of 0.791). In fact, any SNPs
claimed significant using the two methods would be a false posi-
tive. The calculated percentages (Table 4) provide estimates of the
FWER. Bonferroni and Holm’s methods give the same results.
The results suggest that, under the null hypothesis, the FWER
level is controlled for the methods based on both the original
(unweighted) and the weighted p-values. The simulations con-
firm the validity of the weighted hypothesis method (Genovese
et al., 2006).
DISCUSSION
It is of substantial interest to enhance the power for identify-
ing associations in the era of post-GWAS. Besides meta-analysis
that has been proved successful in power gain (Moffatt et al.,
2010), incorporating prior information has also received increas-
ing attention. Such information can be obtained from various
sources and levels, such as linkage analysis (Roeder et al., 2006),
gene expression (Yang et al., 2010), and annotation information
of variants (Adzhubei et al., 2010), genes (Saccone et al., 2007),
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FIGURE 3 | Q–Q plots of original p-values and weighted p-values in the MAGICS analysis. The weighted p-values are based on (A) the general weight, or
(B) the binary weight. The reported asthma-associated SNPs in the GWAS catalog are shown in circles.
Table 1 | Additional significant SNPs or positive results identified by eQTL weighting methods after accounting for linkage disequilibrium in
the MAGICS analysis.
Chr SNP Gene p-value Qg Qb Method
17 rs1877031 STARD3 4.32 × 10−6 1.54 × 10−6 1.17 × 10−6 BH
17 rs931992 TCAP, STARD3 5.61 × 10−6 1.96 × 10−6 1.52 × 10−6 BH
17 rs1565922 PGAP3 7.28 × 10−6 2.55 × 10−6 1.97 × 10−6 BH
17 rs2941504 PGAP3 7.64 × 10−6 2.68 × 10−6 2.06 × 10−6 BH
10 rs11191325 SUFU 8.49 × 10−6 3.37 × 10−6 2.29 × 10−6 BH
Qg and Qb are the eQTL weighted p-values based on the general weight and the binary weight, respectively. Using both weights result in the same set of SNPs.
Table 2 | Additional significant SNPs or positive results identified by eQTL weighting methods after accounting for linkage disequilibrium in
the GABRIEL analysis.
Chr SNP Gene p-value Qg Qb Method
5 rs244749 MEF2C 6.25 × 10−5 2.51 × 10−5 1.54 × 10−5 BH
5 rs10075941 6.13 × 10−5 3.03 × 10−5 1.51 × 10−5 BH
17 rs7503195 7.66 × 10−5 3.07 × 10−5 1.88 × 10−5 BH
17 rs17637472 6.13 × 10−5 3.56 × 10−5 1.51 × 10−5 BH
9 rs7047575 6.87 × 10−5 3.92 × 10−5 1.69 × 10−5 BH
The results are based on the general weight.
and pathways (Wang et al., 2007). The so-called “agnostic” GWAS
may benefit from incorporating useful prior information. In our
study of asthma, gene expression information is of particular
interest, as a recent study (Moffatt et al., 2007) identified several
eQTLs associated with asthma.
In the reanalysis of the MAGICS data (Moffatt et al., 2007), we
applied recently developed statistical methods that can improve
power by weighting hypothesis (Genovese et al., 2006; Roeder
and Wasserman, 2009). Using eQTL information obtained from
an independent dataset, we employed weighted procedures that
up-weighted eQTL SNPs and down-weighted non-eQTL SNPs
while controlling for the FWER or the FDR. It has been proved
(Genovese et al., 2006) that any set of nonnegative weights
can guarantee substantial power gain given informative weights
and little power loss for uninformative weights. The property
implies that the weighted procedures are robust to informa-
tiveness of weights and to the uneven coverage of genes and
expression targets on the genome. We took advantage of this
robustness and applied the procedures to an asthma study. We
found additional SNPs that were significantly associated with
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Table 3 | Additional significant SNPs or positive results identified by eQTL weighting methods after accounting for linkage disequilibrium in
the GABRIEL analysis.
Chr SNP Gene p-value Qg Qb Method
5 rs736801 2.15 × 10−7 8.81× 10−8 5.29 × 10−8 Bonferroni, Holm
6 rs2596450 HCG26 2.72 × 10−7 1.16× 10−7 6.69 × 10−8 Bonferroni, Holm
5 rs10075941 6.13 × 10−5 3.03× 10−5 1.51 × 10−5 BH
17 rs17637472 6.13 × 10−5 3.56× 10−5 1.51 × 10−5 BH
5 rs244749 MEF2C 6.25 × 10−5 2.51× 10−5 1.54 × 10−5 BH
9 rs7047575 6.87 × 10−5 3.92× 10−5 1.69 × 10−5 BH
17 rs7503195 7.66 × 10−5 3.07× 10−5 1.88 × 10−5 BH
6 rs9273363 HLA_DQB1 8.38 × 10−5 4.41× 10−5 2.06 × 10−5 BH
5 rs4351182 9.98 × 10−5 4.91× 10−5 2.45 × 10−5 BH
2 rs13391794 1.01 × 10−4 5.62× 10−5 2.49 × 10−5 BH
5 rs10044342 MEF2C 1.10 × 10−4 4.59× 10−5 2.71 × 10−5 BH
2 rs6751196 1.14 × 10−4 6.22× 10−5 2.80 × 10−5 BH
6 rs176095 PBX2, GPSM3 1.25 × 10−4 5.12× 10−5 3.08 × 10−5 BH
2 rs2675073 1.34 × 10−4 5.40× 10−5 3.29 × 10−5 BH
2 rs1913621 1.46 × 10−4 7.92× 10−5 3.60 × 10−5 BH
2 rs10497621 NUP35 1.59 × 10−4 7.55× 10−5 3.91 × 10−5 BH
5 rs244750 MEF2C 1.70 × 10−4 7.08× 10−5 4.17 × 10−5 BH
6 rs9366689 POM121L2 1.72 × 10−4 8.73× 10−5 4.23 × 10−5 BH
6 rs7775759 1.81 × 10−4 6.43× 10−5 4.46 × 10−5 BH
6 rs7741091 1.81 × 10−4 6.43× 10−5 4.46 × 10−5 BH
8 rs6601649 1.90 × 10−4 9.68× 10−5 4.68 × 10−5 BH
6 rs204994 1.94 × 10−4 8.02× 10−5 4.76 × 10−5 BH
The results are based on the binary weight.
Table 4 | Family-wise error rate estimates in 5000 permutations.
P-value FWER
Original 0.0454
Weighted by general weight 0.0458
Weighted by binary weight 0.0460
Both Bonferroni and Holm’s methods gave the same results in the same
scenarios.
asthma according to the weighting hypothesis methods. Some of
them were interesting after we accounted for LD and compared
them to literature. Our analysis was the first application of
this approach to asthma GWAS studies, and the results suc-
cessfully illustrated the use of eQTL weighting in the context
of asthma studies. As another application, we also reanalyzed
the GABRIEL meta-analysis p-values and reported corresponding
results.
It is noted that the weighted procedures can utilize eQTL
information from a reference database. Multiple choices of eQTL
databases have already been made available (e.g., Yang et al.,
2010; Liang et al., 2013), and future efforts may provide even
better reference of eQTL information. For example, the eQTL
information considered in our reanalysis was obtained through
a single platform (Affymetrix HG-U133 Plus 2.0), and better
coverage of gene expression profiling may be achieved through
RNA-Seq technologies or by combining information from various
platforms.
Besides the weighted procedures, an alternative method of
using eQTL information is to simply test association between
eQTL SNPs and the trait of interest. Such a method is not rec-
ommended in GWAS as it excludes non-eQTL completely and
relies on the prior information too heavily. By contrast, weighted
procedures make it possible to consider eQTLs and non-eQTLs
simultaneously. More importantly, they can possibly increase
power if the prior information is useful and are able to maintain
the type I error under the null.
Applying the weighted procedures in our reanalysis only
requires p-value of eQTL SNPs. This flexibility means that such
analyses can be applied to any existing GWAS data, even if they
do not have accompanying gene expression data. Although gene
expression may have tissue-specific patterns, a substantial frac-
tion of eQTLs may be shared across tissues (Ding et al., 2010).
Hence eQTLs developed from tissues that are not directly relevant
to the outcome of interest, such as those from publicly available
eQTL databases based on LCL, can be used to improve power on
GWAS. It is possible that using eQTL information from relevant
tissues may result in even more power gain, if such information is
available.
Besides the particular weighting hypothesis method (Genovese
et al., 2006) we adopted, Bayesian methods are potentially alter-
native strategies to incorporate eQTL information. The use of
Bayes factors has been applied to genetic association studies
(Wellcome Trust Case Control Consortium, 2007; Stephens and
Balding, 2009). In single SNP analysis, a prior is assumed for
each SNP effect [e.g., N(0, 0.22) under a model of association in
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Wellcome Trust Case Control Consortium (2007)]. eQTL infor-
mation can be naturally incorporated into the prior, although
it may be challenging to choose a realistic yet tractable alter-
native model and to assess error rates (Hoggart et al., 2008),
especially with the eQTL weight. One possible choice is through
modifying the variance of the prior, for example assuming a
prior N(0.22w), where w is a weight of eQTL signal. Another
possible choice is to keep the variance the same and increase
the probability of association for eQTLs a priori. It is of inter-
est in future research to explore these possibilities and con-
sider the extension of Bayesian methods to incorporate eQTL
information.
In our analysis, we took into account the LD between SNPs
by considering the effective number of SNPs (Li et al., 2012).
As an alternative, testing SNP sets for association has potential
of improving power and reducing the correlation between tests.
Since the focus of this paper is to demonstrate the use of eQTL
information in association testing, we will consider the weighted
correlated hypothesis in future research.
Two choices of weights were applied in our analysis includ-
ing a binary weight and a weight using strength of eQTLs, and
the results using the two weights were similar in our analysis.
Theoretical results exist (Roeder and Wasserman, 2009) for the
optimal binary weight, which provide guidance in choosing the
values of the weight. The weight taking advantage of the eQTL
strength may possibly provide more useful information, and what
is the best choice of weights is still under research.
Through an application to an asthma GWAS, we demon-
strated the usefulness of eQTL weights in GWAS. Although
results may vary depending on the traits of interest and the
underlying biological mechanism, the potentials of increas-
ing power and little investment required for reanalysis make
the eQTL-weighted procedures desirable for reanalysis of exist-
ing GWAS data and useful for design and analysis of future
studies.
MATERIALS AND METHODS
THE MAGICS ASTHMA GWAS SAMPLES AND DATA
TheMAGICS (Multicentre Asthma Genetics in Childhood Study)
study data (Moffatt et al., 2007), part of the GABRIEL con-
sortium, were reanalyzed by incorporating eQTL information.
Quality control procedures were conducted similarly to a pub-
lished protocol (Anderson et al., 2010). Individuals with missing
phenotypes, elevated missing rates (≥5%), or outlying heterozy-
gosity rate were removed. Markers with an excessive missing rate
(≥5%), low MAF (<5%), or failing in the HWE test (p-value <
10−5) were all excluded as well. The remaining dataset contains
1296 individuals (647 affected and 649 unaffected) genotyped
across 300,821 SNPs.
To account for possible divergent ancestry and population
stratification, principal component analysis (PCA) was con-
ducted using EIGENSOFT 4.2 (Patterson et al., 2006; Price et al.,
2006). The genotype data were pruned for LD prior to the PCA.
The PCA result (Figure A1) suggests that no obvious stratifica-
tion exists, and the signal of the first principal component is
very weak. In the subsequent analysis, we still included the first
principal component as a covariate.
LD pruning was considered only in the calculation of enrich-
ment p-value. It was conducted using PLINK (v1.07, downloaded
from http://pngu.mgh.harvard.edu/purcell/plink/) (Purcell et al.,
2007). A moving window with a width of 50 SNPs and a step
size of 5 SNPs was considered, and pairwise LDs were calcu-
lated and pruned if r2 > 0.8 (corresponding PLINK arguments:
“–indep-pairwise 50 5 0.8”).
THE GABRIEL META-ANALYSIS p-VALUES
Association testing results, including SNP ID and p-values, were
obtain from a reanalysis of the GABRIEL consortium data using
imputed SNPs (Bouzigon et al., personal communication). The
meta-analysis considered imputation of SNP genotypes using the
HapMap 2 reference data for 37 studies, and calculated a meta-
analysis p-value for each SNP using available data. Imputed SNPs
were kept for analysis if their imputation scores (Rsq) were ≥0.5
and if their minor allele frequencies were ≥1%. In total there were
2,473,850 SNPs that passed the quality control. Only the SNP ID
and the p-values of these SNPs were obtained and used for the
reanalysis described in this paper.
EXPRESSION QUANTITATIVE TRAIT LOCI DATA
An eQTL database (http://www.hsph.harvard.edu/liming-liang/
software/eqtl/) resulting from an independent dataset was used
as prior information to be incorporated in the GWAS. The sam-
ple contains 405 siblings from a panel of families of British
descent (MRC-A) (Dixon et al., 2007). Global gene expression
in LCLs was measured using Affymetrix HG-U133 Plus 2.0
chips. All siblings were genotyped using the Illumina Sentrix
HumanHap300 BeadChip (ILMN300K) and/or the Illumina
Sentrix Human-1 Genotyping BeadChip (ILMN100K). The SNP
genotype data were further imputed using the MaCH program,
and each SNP was tested for association with probes in the
gene expression data. Restricting to cis eQTLs (1Mb region)
and controlling for the FDR of 1%, there are 515,947 tests
with logarithm of odds (LOD) scores greater than 3.172, corre-
sponding to 268,204 unique SNPs. In case a SNP has multiple
p-values reported for associations with different probes, the min-
imal p-value was used for that SNP. These 268,204 SNPs are
considered as eQTLs, and the database contains information
of their physical positions, LOD scores, p-values, and resid-
ing or nearby genes. Details of the database are described by
Liang et al. (2013).
GENETIC ASSOCIATION ANALYSIS
Genetic association analysis of the MAGICS data was conducted
in PLINK. Logistic regression was used to test for disease-trait
SNP association while adjusted for gender and the first princi-
pal component. Meta-analysis on GABRIEL data was carried out
by combining association results from 37 studies using a ran-
dom effect model, and all computations were done using Stata
software.
p-VALUE WEIGHTINGMETHODS
Consider m hypotheses H1, . . . ,Hm and their test statis-
tic p-values, P1, . . . ,Pm. Suppose there are weights
W1, . . . ,Wm available for the m tests, respectively, satisfying
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Wi > 0 and
∑m
i=1 Wi = m. Define Qi = Pi/Wi and let Q(1) ≤· · · ≤ Q(m) be the sorted values. Let P(1), . . . , P(m) and
W(1), . . . ,W(m) be the values in the corresponding order. Qi is
sometimes referred to a “weighted p-value” (e.g., Roeder and
Wasserman, 2009), although it is not a p-value.
The weighted Bonferroni procedure is to reject any hypothe-
sis Hj (1 ≤ j ≤ m) that satisfies Qj ≤ α/m, where α is the desired
level of FWER. Genovese et al. (2006) showed that this procedure
controls FWER at level no greater than α.
Holm’s weighted procedure (1979) is carried out as fol-
lows: given the desired α level of FWER, if Q(1) ≥ α/m, no
hypothesis is rejected; otherwise, find the largest j that satis-
fies Q(i) ≤ α/∑mk=i W(k) for all i ≤ j, and reject the hypotheses
corresponding to the j smallest Qj’s. Genovese et al. (2006)
also prove that this procedure can work for a general setting
of weights.
We also consider Benjamini and Hochberg’s procedure (1995)
for controlling FDR. Given the desired level α, find the largest j
such that Q(j) ≤ α · j/m, and reject the hypotheses correspond-
ing to the j smallest Qj’s. Genovese et al. (2006) prove that this
procedure controls FDR at level α.
eQTL INFORMATION AS WEIGHTS
The eQTL p-values were used to construct weights for the SNPs
in the asthma GWAS reanalysis. We considered two kinds of
weights, the binary weight wb and the general weight wg . The
binary weight takes only two possible values that are predefined,
denoted by weQTL and wnon−eQTL. For m hypotheses, a binary
weight is defined as wb = (wb,1, . . . ,wb,m) where wb,j = weQTL
if the jth SNP is an eQTL SNP, and wb,j = wnon−eQTL if it is
not an eQTL SNP. Given the values of α, β, and , the opti-
mal values of weQTL and wnon−eQTL were chosen (Roeder and
Wasserman, 2009) to maximize the minimum power among all
the hypotheses while having at least a fraction  with high power
1 − β. Here α is either the level of FWER or FDR. We also con-
sidered a general weight, where the weight wg = (wg,1, . . . ,wg,m)
has wg,j =
√−log10peQTL if the jth SNP is an eQTL SNP with the
eQTL p-value peQTL, and wg,j = 1 otherwise. The particular form
was intuitively chosen prior to the reanalysis of the GWAS data
in consideration of avoiding up-weighting top eQTL SNPs too
much. Both wb and wg were then normalized such that the means
equal to 1, i.e., wB = 1 and wG = 1.
REPORTED ASSOCIATIONS IN THE GWAS CATALOG
Asthma-associated SNPs and genes reported in publications
were retrieved from the online catalog of published GWAS
on January 15, 2013. The catalog limits the associations to
those with p-values less than 1.0 × 10−5 and records only one
SNP with a gene or region of high LD unless there was evi-
dence of independent association. The reported associations were
compared against the findings in the asthma GWAS data we
reanalyzed.
LINKAGE DISEQUILIBRIUM INFORMATION
To account for LD between SNPs, LD information based on
HapMap 2 was obtained. The SNAP proxy search tool (http://
www.broadinstitute.org/mpg/snap/ldsearch.php) was used to
obtain the information, based on the HapMap 2 (rel22) reference
and a distance limit of 500kb.
SIZE SIMULATION USING THE ASTHMA GWAS DATA
Besides analyzing the MAGICS asthma GWAS data, we also
conducted size simulations by permuting the disease status
in the data. Logistic regression was considered where the
dependent variable was the disease status (affected or unaf-
fected) and the independent variables included a single SNP
effect, gender, and the first principal component. The regres-
sion was applied to all the ∼300,000 SNPs across the whole
genome. Five thousand permutations were done by permut-
ing the disease status among all the individuals, and then
the model was refitted for each SNP. In the end of simula-
tions, 5000 permutation p-values were obtained for each of
the ∼300,000 SNPs.
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RESOURCES
R functions have been made available for users’ convenience
to compute the eQTL weighted p-values in order to conduct
weighted procedures such as Bonferroni, Holm’s and Benjamini–
Hochberg procedures. The functions can be found at http://www.
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REFERENCES
Adzhubei, I. A., Schmidt, S., Peshkin,
L., Ramensky, V. E., Gerasimova, A.,
Bork, P., et al. (2010). A method
and server for predicting damaging
missensemutations.Nat.Methods 7,
248–249. doi: 10.1038/nmeth0410-
248
Anantharaman, R., Andiappan, A. K.,
Nilkanth, P. P., Suri, B. K., Wang, D.
Y., and Chew, F. T. (2011). Genome-
wide association study identifies
PERLD1 as asthma candidate gene.
BMC Med. Genet. 12:170. doi:
10.1186/1471-2350-12-170
Anderson, C. A., Pettersson, F. H.,
Clarke, G. M., Cardon, L. R.,
Morris, A. P., and Zondervan, K.
T. (2010). Data quality control
in genetic case-control association
studies. Nat. Protoc. 5, 1564–1573.
doi: 10.1038/nprot.2010.116
Benjamini, Y., and Hochberg, Y.
(1995). Controlling the false discov-
ery rate: a practical and powerful
approach to multiple testing. J. R.
Stat. Soc. Ser. B 57, 289–300. doi:
10.2307/2346101
Bonferroni, C. E. (1936).
Teoria statistica delle classi
e calcolo delle probabilità.
Pubblicazioni del R Istituto
Superiore di Scienze Economiche
e Commerciali di Firenze 8,
3–62.
Bouzigon, E., Corda, E., Aschard,
H., Dizier, M. H., Boland, A.,
Bousquet, J., et al. (2008). Effect
of 17q21 variants and smoking
exposure in early-onset asthma. N.
Frontiers in Genetics | Statistical Genetics and Methodology May 2013 | Volume 4 | Article 103 | 8
Li et al. eQTL weighting for GWAS
Engl. J. Med. 359, 1985–1994. doi:
10.1056/NEJMoa0806604
Chu, X., Pan, C.-M., Zhao, S.-X., Liang,
J., Gao, G.-Q., Zhang, X.-M., et al.
(2011). A genome-wide association
study identifies two new risk loci
for Graves’ disease. Nat. Genet. 43,
897–901. doi: 10.1038/ng.898
Cookson, W., Liang, L., Abecasis,
G., Moffatt, M., and Lathrop, M.
(2009). Mapping complex disease
traits with global gene expression.
Nat. Rev. Genet. 10, 184–194. doi:
10.1038/nrg2537
Cookson, W. (2004). The immuno-
genetics of asthma and eczema:
a new focus on the epithelium.
Nat. Rev. Immunol. 4, 978–988. doi:
10.1038/nri1500
Dimas, A. S., Deutsch, S., Stranger,
B. E., Montgomery, S. B., Borel,
C., Attar-Cohen, H., et al. (2009).
Common regulatory variation
impacts gene expression in a
cell type-dependent manner.
Science 325, 1246–1250. doi:
10.1126/science.1174148
Ding, J., Gudjonsson, J. E., Liang, L.,
Stuart, P. E., Li, Y., Chen, W., et al.
(2010). Gene expression in skin
and lymphoblastoid cells: refined
statistical method reveals extensive
overlap in cis-eQTL signals. Am.
J. Hum. Genet. 87, 779–789. doi:
10.1016/j.ajhg.2010.10.024
Dixon, A. L., Liang, L., Moffatt, M. F.,
Chen,W., Heath, S., Wong, K. C. C.,
et al. (2007). A genome-wide asso-
ciation study of global gene expres-
sion.Nat. Genet. 39, 1202–1207. doi:
10.1038/ng2109
Genovese, C. R., Roeder, K., and
Wasserman, L. (2006). False dis-
covery control with p-value weight-
ing. Biometrika 93, 509–524. doi:
10.1198/jasa.2010.tm09329
Heid, I. M., Jackson, A. U., Randall,
J. C., Winkler, T. W., Qi, L.,
Steinthorsdottir, V., et al. (2010).
Meta-analysis identifies 13 new
loci associated with waist-hip ratio
and reveals sexual dimorphism in
the genetic basis of fat distribu-
tion. Nat. Genet. 42, 949–960. doi:
10.1038/ng.685
Hoggart, C. J., Clark, T. G., De Iorio,
M., Whittaker, J. C., and Balding, D.
J. (2008). Genome-wide significance
for dense SNP and resequencing
data. Genet. Epidemiol. 32, 179–185.
doi: 10.1002/gepi.20292
Holm, S. (1979). A simple sequen-
tially rejective multiple test proce-
dure. Scand. J. Stat. 6, 65–70. doi:
10.2307/4615733
Hosack, D. A., Dennis, G. Jr., Sherman,
B. T., Lane, H. C., and Lempicki,
R. A. (2003). Identifying biological
themes within lists of genes with
EASE. Genome Biol. 4:R70. doi:
10.1186/gb-2003-4-10-r70
Hsu, Y.-H., Zillikens, M. C., Wilson,
S. G., Farber, C. R., Demissie,
S., Soranzo, N., et al. (2010).
An integration of genome-wide
association study and gene expres-
sion profiling to prioritize the
discovery of novel susceptibil-
ity Loci for osteoporosis-related
traits. PLoS Genet. 6:e1000977. doi:
10.1371/journal.pgen.1000977
Johnson, A. D., Handsaker, R. E., Puilt,
S., Nizzari, M. M., O’Donnell, C. J.,
and de Bakker, P. I. W. (2008).
SNAP: a web-based tool for iden-
tification and annotation of proxy
SNPs using HapMap. Bioinformatics
24, 2938–2939. doi: 10.1093/bioin-
formatics/btn564
Lango Allen, H., Estrada, K., Lettre,
G., Berndt, S. I., Weedon, M.
N., Rivadeneira, F., et al. (2010).
Hundreds of variants clustered
in genomic loci and biolog-
ical pathways affect human
height. Nature 467, 832–838.
doi: 10.1038/nature09410
Li, M. X., Yeung, J. M. Y., Cherny, S. S.,
and Sham, P. C. (2012). Evaluating
the effective numbers of indepen-
dent tests and significant p-value
thresholds in commercial genotyp-
ing arrays and public imputation
reference datasets. Hum. Genet. 131,
747–756. doi: 10.1007/s00439-011-
1118-2
Liang, L., Morar, N., Dixon, A. L.,
Lathrop, G. M., Abecasis, G. R.,
Moffatt, M. F., et al. (2013). A
cross-platform catalogue of 14, 177
expression quantitative trait loci
derived from lymphoblastoid cell
lines. Genome Res. 23, 716–726. doi:
10.1101/gr.142521.112
Moffatt, M. F., Kabesch, M., Liang, L.,
Dixon, A. L., Strachan, D., Heath, S.,
et al. (2007). Genetic variants reg-
ulating ORMDL3 expression con-
tribute to the risk of childhood
asthma. Nature 448, 470–473. doi:
10.1038/nature06014
Moffatt, M. F., Gut, I. G., Demenais, F.,
Strachan, D. P., Bouzigon, E., Heath,
S., et al. (2010). A large-scale,
consortium-based genomewide
association study of asthma. N.
Engl. J. Med. 363, 1211–1221. doi:
10.1056/NEJMoa0906312
Nica, A. C., Parts, L., Glass, D.,
Nisbet, J., Barrett, A., Sekowska,
M., et al. (2011). The architec-
ture of gene regulatory variation
across multiple human tissues:
the MuTHER study. PLoS Genet.
7:e1002003. doi: 10.1371/journal.
pgen.1002003
Nicolae, D. L., Gamazon, E., Zhang, W.,
Duan, S., Dolan, M. E., and Cox,
N. J. (2010). Trait-associated SNPs
are more likely to be eQTLs: anno-
tation to enhance discovery from
GWAS. PLoS Genet. 6:e1000888.
doi: 10.1371/journal.pgen.1000888
Patterson, N., Price, A. L., and Reich,
D. (2006). Population structure
and eigenanalysis. PLoS Genet.
2:e190. doi: 10.1371/journal.pgen.
0020190
Price, A. L., Patterson, N. J., Plenge, R.
M., Weinblatt, M. E., Shadick, N.
A., and Reich, D. (2006). Principal
components analysis corrects for
stratification in genome-wide asso-
ciation studies. Nat. Genet. 38,
904–909. doi: 10.1038/ng1847
Purcell, S., Neale, B., Todd-Brown, K.,
Thomas, L., Ferreira, M. A. R.,
Bender, D., et al. (2007). PLINK: a
tool set for whole-genome associa-
tion and population-based linkage
analyses. Am. J. Hum. Genet. 81,
559–575. doi: 10.1086/519795
Roeder, K., and Wasserman, L. (2009).
Genome-wide significance levels
and weighted hypothesis test-
ing. Stat. Sci. 24, 398–413. doi:
10.1214/09-STS289
Roeder, K., Bacanu, S.-A., Wasserman,
L., and Devlin, B. (2006). Using
linkage genome scans to improve
power of association in genome
scans. Am. J. Hum. Genet. 78,
243–252. doi: 10.1086/500026
Roeder, K., Devlin, B., and Wasserman,
L. (2007). Improving power in
genome-wide association stud-
ies: weights tip the scale. Genet.
Epidemiol. 31, 741–747. doi:
10.1002/gepi.20237
Saccone, S. F., Hinrichs, A. L., Saccone,
N. L., Chase, G. A., Konvicka,
K., Madden, P., et al. (2007).
Cholinergic nicotinic receptor genes
implicated in a nicotine dependence
association study targeting 348
candidate genes with 3713 SNPs.
Hum. Mol. Genet. 16, 36–49. doi:
10.1093/hmg/ddl438
Speliotes, E. K., Willer, C. J., Berndt,
S. I., Monda, K. L., Thorleifsson,
G., Jackson, A. U., et al. (2010).
Association analyses of 249, 796
individuals reveal 18 new loci
associated with body mass index.
Nat. Genet. 42, 937–948. doi:
10.1038/ng.686
Stephens, M., and Balding, D. (2009).
Bayesian statistical methods
for genetic association studies.
Nat. Rev. Genet. 10, 681–690.
doi:10.1038/nrg2615
Storey, J. D., and Tibshirani, R.
(2003). Statistical significance for
genomewide studies. Proc. Natl.
Acad. Sci. U.S.A. 100, 9440–9445.
doi: 10.1073/pnas.1530509100
Stranger, B. E., Forrest, M. S., Clark, A.
G., Minichiello, M. J., Deutsch, S.,
Lyle, R., et al. (2005). Genome-wide
associations of gene expression vari-
ation in humans. PLoS Genet. 1:e78.
doi: 10.1371/journal.pgen.0010078
Stranger, B. E., Nica, A. C., Forrest,
M. S., Dimas, A., Bird, C. P.,
Beazley, C., et al. (2007). Population
genomics of human gene expres-
sion.Nat. Genet. 39, 1217–1224. doi:
10.1038/ng2142
Stranger, B. E., Montgomery, S. B.,
Dimas, A. S., Parts, L., Stegle,
O., Ingle, C. E., et al. (2012).
Patterns of cis regulatory varia-
tion in diverse human popula-
tions. PLoS Genet. 8:e1002639. doi:
10.1371/journal.pgen.1002639
Teslovich, T. M., Musunuru, K., Smith,
A. V., Edmondson, A. C., Stylianou,
I. M., Koseki, M., et al. (2010).
Biological, clinical and population
relevance of 95 loci for blood
lipids. Nature 466, 707–713. doi:
10.1038/nature09270
Wang, K., Li, M., and Bucan, M.
(2007). Pathway-based approaches
for analysis of genomewide associa-
tion studies. Am. J. Hum. Genet. 81,
1278–1283. doi: 10.1086/522374
Wellcome Trust Case Control
Consortium. (2007). Genome-
wide association study of 14, 000
cases of seven common diseases and
3, 000 shared controls. Nature 447,
661–678. doi: 10.1038/nature05911
Wu, C., Miao, X., Huang, L., Che,
X., Jiang, G., Yu, D., et al.
(2012). Genome-wide associ-
ation study identifies five loci
associated with susceptibility to
pancreatic cancer in Chinese
populations. Nat. Genet. 44,
62–66. doi: 10.1038/ng.1020
Xiong, Q., Ancona, N., Hauser, E.
R., Mukherjee, S., and Furey, T. S.
(2012). Integrating genetic and gene
expression evidence into genome-
wide association analysis of gene
sets. Genome Res. 22, 386–397. doi:
10.1101/gr.124370.111
Yang, T.-P., Beazley, C., Montgomery, S.
B., Dimas, A. S., Gutierrez-Arcelus,
M., Stranger, B. E., et al. (2010).
Genevar: a database and Java appli-
cation for the analysis and visu-
alization of SNP-gene associations
in eQTL studies. Bioinformatics 26,
2474–2476. doi: 10.1093/bioinfor-
matics/btq452
Zhang, M., Liang, L., Morar, N., Dixon,
A. L., Lathrop, G. M., Ding, J., et al.
(2012). Integrating pathway analy-
sis and genetics of gene expression
for genome-wide association study
www.frontiersin.org May 2013 | Volume 4 | Article 103 | 9
Li et al. eQTL weighting for GWAS
of basal cell carcinoma.Hum. Genet.
131, 615–623. doi: 10.1007/s00439-
011-1107-5
Zhong, H., Yang, X., Kaplan, L.
M., Molony, C., and Schadt, E. E.
(2010). Integrating pathway analysis
and genetics of gene expression for
genome-wide association studies.
Am. J. Hum. Genet. 86, 581–591.
doi: 10.1016/j.ajhg.2010.02.020
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 16 August 2012; accepted: 21
May 2013; published online: 31 May
2013.
Citation: Li L, Kabesch M, Bouzigon
E, Demenais F, Farrall M, Moffatt MF,
Lin X and Liang L (2013) Using eQTL
weights to improve power for genome-
wide association studies: a genetic study
of childhood asthma. Front. Genet.
4:103. doi: 10.3389/fgene.2013.00103
This article was submitted to Frontiers in
Statistical Genetics and Methodology, a
specialty of Frontiers in Genetics.
Copyright © 2013 Li, Kabesch,
Bouzigon, Demenais, Farrall, Moffatt,
Lin and Liang. This is an open-access
article distributed under the terms of the
Creative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, provided
the original authors and source are cred-
ited and subject to any copyright notices
concerning any third-party graphics etc.
Frontiers in Genetics | Statistical Genetics and Methodology May 2013 | Volume 4 | Article 103 | 10
Li et al. eQTL weighting for GWAS
APPENDIX
FIGURE A1 | Principal components analysis for the MAGICS study. The scatter plots of (A) PC1 vs. PC2, and (B) PC2 vs. PC3 are shown, with each
circle corresponding to an individual in the asthma GWAS.
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Table A1 | Published asthma associated SNPs in the GWAS catalog as of January 15, 2013.
Region Chr SNP Context Gene eQTL
1q21.3 1 rs4129267 Intron IL6R
1q23.1 1 rs1101999 Intron PYHIN1
1q21.3 1 rs4845783 Intergenic CRCT1
1q31.3 1 rs2786098 Intron DENND1B, CRB1
2q12.1 2 rs13408661 Intron IL1RL1, IL18R1
2q12.1 2 rs9807989 Intergenic IL18R1,IL1R1
2q12.1 2 rs3771180 Intron IL1RL1
2q12.1 2 rs3771166 Intron IL18R1 Y
4q31.21 4 rs7686660 Intergenic LOC729675
4q31.21 4 rs3805236 Intron GAB1
5q31.3 5 rs6867913 Intergenic NDFIP1
5q31.1 5 rs11745587 Intron C5orf56 Y
5q22.1 5 rs1837253 Intergenic TSLP
5q31.1 5 rs1295686 Intron IL13
5q31.1 5 rs2073643 Intron SLC22A5 Y
5q31.1 5 rs2244012 Intron RAD50 Y
5q12.1 5 rs1588265 Intron PDE4D
6p21.32 6 rs9268516 Intergenic BTNL2, HLA-DRA
6q27 6 rs6456042 Intergenic T
6p21.32 6 rs9500927 Intergenic HLA-DOA Y
6p21.32 6 rs9275698 Intergenic HLA-DQA2 Y
6p21.32 6 rs7775228 Intergenic HLA-DQB1 Y
6p21.32 6 rs3129890 Intergenic HLA-DRA
6p21.32 6 rs3117098 Intergenic BTNL2 Y
6p21.32 6 rs204993 Intron PBX2 Y
6p21.32 6 rs404860 Intron NOTCH4
6p21.32 6 rs3129943 Intron C6orf10 Y
6p21.32 6 rs987870 Intron; nearGene-5 HLA, DPB1 Y
6p21.32 6 rs9273349 Intergenic HLA-DQ
8q24.11 8 rs3019885 Intron SLC30A8
9p21.1 9 rs10970976 Intron ACO1
9p24.1 9 rs2381416 Intergenic IL33
9p24.1 9 rs1342326 Intergenic IL33
10q21.1 10 rs7922491 Intron PRKG1
10p14 10 rs10508372 Intergenic LOC338591
11q13.5 11 rs7130588 Intergenic LRRC32
11q23.2 11 rs11214966 Intergenic C11orf71
12q13.2 12 rs1701704 Intergenic IKZF4 Y
12q13.2 12 rs2069408 Intron CDK2 Y
13q21.31 13 rs3119939 Intergenic PCDH20
15q22.2 15 rs11071559 Intron RORA
15q22.33 15 rs744910 Intron SMAD3
15q21.2 15 rs17525472 Intergenic SCG3 Y
17q12 17 rs4794820 Intergenic ORMDL3 Y
17q12 17 rs11078927 Intron GSDMB Y
17q12 17 rs6503525 Intergenic ORMDL3 Y
17q21.1 17 rs3894194 Missense GSDMA Y
17q12 17 rs2305480 Missense GSDMB Y
17q12 17 rs7216389 Intron ORMDL3 Y
19q13.42 19 rs16984547 Intron ZNF665
20p13 20 rs4815617 nearGene-5 KIAA1271
22q12.3 22 rs2284033 Intron IL2RB
“Y” in the eQTL column means the corresponding SNP is an eQTL SNP according to the eQTL database described in Materials and Methods. “nearGene-5” is an
NCBI dbSNP function code, meaning that SNP is 5′ to and 2kb away from a gene.
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Table A2 | The significant SNPs identified by the unweighted method and the weighted methods (using general weight or binary weight) in
the MAGICS analysis.
Rank Unweighted method General weight Binary weight
Chr SNP p-value Chr SNP Qg Chr SNP Qb
1 17 rs3894194* 4.01E-09 17 rs3894194* 1.68E-09 17 rs3894194* 1.08E-09
2 17 rs8079416* 6.86E-09 17 rs8079416* 2.70E-09 17 rs8079416* 1.85E-09
3 17 rs4795408* 2.40E-08 17 rs4795408* 9.66E-09 17 rs4795408* 6.49E-09
4 17 rs3859192 3.58E-08 17 rs2290400* 1.75E-08 17 rs2290400* 2.00E-08
5 17 rs2290400* 7.39E-08 17 rs7216389* 1.76E-08 17 rs7216389* 2.02E-08
6 17 rs7216389* 7.48E-08 17 rs3859192 4.31E-08 17 rs3859192 5.25E-08
7 17 rs3902025* 1.05E-07 17 rs3902025* 7.44E-08
8 17 rs4795405* 1.07E-07 17 rs4795405* 9.83E-08
9 17 rs2305480* 1.40E-07 17 rs2305480* 1.54E-07
Bonferroni’s correction is used with an FWER level of 0.05. *eQTL.
Table A3 | The significant SNPs identified by the unweighted method and the weighted methods (using general weight or binary weight) in
the MAGICS analysis.
Rank Unweighted method General weight Binary weight
Chr SNP p-value Chr SNP Qg Chr SNP Qb
1 17 rs3894194* 4.01E-09 17 rs3894194* 1.68E-09 17 rs3894194* 1.08E-09
2 17 rs8079416* 6.86E-09 17 rs8079416* 2.70E-09 17 rs8079416* 1.85E-09
3 17 rs4795408* 2.40E-08 17 rs4795408* 9.66E-09 17 rs4795408* 6.49E-09
4 17 rs3859192 3.58E-08 17 rs2290400* 1.75E-08 17 rs2290400* 2.00E-08
5 17 rs2290400* 7.39E-08 17 rs7216389* 1.76E-08 17 rs7216389* 2.02E-08
6 17 rs7216389* 7.48E-08 17 rs3859192 4.31E-08 17 rs3859192 5.25E-08
7 17 rs3902025* 1.05E-07 17 rs3902025* 7.44E-08
8 17 rs4795405* 1.07E-07 17 rs4795405* 9.83E-08
9 17 rs2305480* 1.40E-07 17 rs2305480* 1.54E-07
Holm’s method is used with an FWER level of 0.05. *eQTL.
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Table A4 | The positive results (SNPs) given by the unweighted method and the weighted methods (using general weight or binary weight) in
the MAGICS analysis.
Rank Unweighted method General weight Binary weight
Chr SNP p-value Chr SNP Qg Chr SNP Qb
1 17 rs3894194* 4.01E-09 17 rs3894194* 1.68E-09 17 rs3894194* 1.08E-09
2 17 rs8079416* 6.86E-09 17 rs8079416* 2.70E-09 17 rs8079416* 1.85E-09
3 17 rs4795408* 2.40E-08 17 rs4795408* 9.66E-09 17 rs4795408* 6.49E-09
4 17 rs3859192 3.58E-08 17 rs2290400* 1.75E-08 17 rs2290400* 2.00E-08
5 17 rs2290400* 7.39E-08 17 rs7216389* 1.76E-08 17 rs7216389* 2.02E-08
6 17 rs7216389* 7.48E-08 17 rs3859192 4.31E-08 17 rs3859192 5.25E-08
7 17 rs3902025* 2.75E-07 17 rs4795405* 1.07E-07 17 rs3902025* 7.44E-08
8 17 rs4795405* 3.64E-07 17 rs3902025* 1.05E-07 17 rs4795405* 9.83E-08
9 17 rs2305480* 5.68E-07 17 rs2305480* 1.40E-07 17 rs2305480* 1.54E-07
10 17 rs11557467 2.19E-06 17 rs8067378* 4.58E-07 17 rs8067378* 5.45E-07
11 17 rs8067378* 2.02E-06 17 rs9303277* 7.94E-07 17 rs9303277* 9.30E-07
12 17 rs1877031* 1.54E-06 17 rs1877031* 1.17E-06
13 17 rs907092* 1.56E-06 17 rs931992* 1.52E-06
14 17 rs931992* 1.96E-06 17 rs907092 1.68E-06
15 17 rs2941504* 2.68E-06 17 rs2941504∗ 2.06E-06
16 17 rs1565922∗ 2.55E-06 17 rs1565922∗ 1.97E-06
17 17 rs11557467 2.64E-06 10 rs11191325∗ 2.29E-06
18 10 rs11191325∗ 3.37E-06 17 rs11557467 3.22E-06
19 17 rs1007654∗ 3.11E-06
The BH procedure is used with an FDR level of 0.05. *eQTL.
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